Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly SG&A expense is $6.43 Billion with a quarter-over-quarter change of +6.60%. Selling, General & Administrative (SG&A) expenses include all costs related to selling products and running the business that are not directly tied to production.
Reported quarterly SG&A expense; no daily interpolation.
$6.43B
$6.43 Billion
+6.60%
vs. $6.03B prior quarter
96
Quarters of data available
| Period | SG&A Expense | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $6.43B | +$398.00M | +6.60% |
| Quarter ended Mar 2026 | $6.03B | −$719.00M | -10.65% |
| Quarter ended Dec 2025 | $6.75B | +$831.00M | +14.03% |
| Quarter ended Sep 2025 | $5.92B | +$133.00M | +2.30% |
| Quarter ended Jun 2025 | $5.79B | +$777.00M | +15.50% |
| Quarter ended Mar 2025 | $5.01B | −$1.24B | -19.85% |
| Quarter ended Dec 2024 | $6.25B | +$975.00M | +18.47% |
| Quarter ended Sep 2024 | $5.28B | −$203.00M | -3.70% |
| Quarter ended Jun 2024 | $5.48B | +$424.00M | +8.38% |
| Quarter ended Mar 2024 | $5.06B | −$453.00M | -8.22% |
| Quarter ended Dec 2023 | $5.51B | +$410.00M | +8.04% |
| Quarter ended Oct 2023 | $5.10B | +$104.00M | +2.08% |
| Quarter ended Jul 2023 | $5.00B | +$490.00M | +10.87% |
| Quarter ended Apr 2023 | $4.51B | −$2.91B | -39.21% |
| Quarter ended Dec 2022 | $7.41B | +$2.74B | +58.55% |
| Quarter ended Oct 2022 | $4.67B | −$1.25B | -21.11% |
| Quarter ended Jul 2022 | $5.93B | +$288.00M | +5.11% |
| Quarter ended Apr 2022 | $5.64B | −$2.02B | -26.34% |
| Quarter ended Dec 2021 | $7.65B | +$1.85B | +31.97% |
| Quarter ended Oct 2021 | $5.80B | −$173.00M | -2.90% |
| Quarter ended Jul 2021 | $5.97B | +$741.00M | +14.16% |
| Quarter ended Apr 2021 | $5.23B | −$1.23B | -18.97% |
| Quarter ended Dec 2020 | $6.46B | +$1.13B | +21.12% |
| Quarter ended Sep 2020 | $5.33B | +$438.00M | +8.95% |
| Quarter ended Jun 2020 | $4.89B | −$310.00M | -5.96% |
| Quarter ended Mar 2020 | $5.20B | −$836.00M | -13.84% |
| Quarter ended Dec 2019 | $6.04B | +$665.00M | +12.37% |
| Quarter ended Sep 2019 | $5.37B | −$172.00M | -3.10% |
| Quarter ended Jun 2019 | $5.55B | +$327.00M | +6.27% |
| Quarter ended Mar 2019 | $5.22B | −$772.00M | -12.89% |
| Quarter ended Dec 2018 | $5.99B | +$448.00M | +8.08% |
| Quarter ended Sep 2018 | $5.54B | −$200.00M | -3.48% |
| Quarter ended Jul 2018 | $5.74B | +$480.00M | +9.12% |
| Quarter ended Apr 2018 | $5.26B | −$762.00M | -12.65% |
| Quarter ended Dec 2017 | $6.03B | +$602.00M | +11.10% |
| Quarter ended Oct 2017 | $5.42B | +$134.00M | +2.53% |
| Quarter ended Jul 2017 | $5.29B | +$526.00M | +11.04% |
| Quarter ended Apr 2017 | $4.76B | −$546.00M | -10.28% |
| Quarter ended Dec 2016 | $5.31B | +$537.00M | +11.25% |
| Quarter ended Oct 2016 | $4.77B | −$404.00M | -7.81% |
| Quarter ended Jul 2016 | $5.18B | +$488.00M | +10.41% |
| Quarter ended Apr 2016 | $4.69B | −$1.20B | -20.42% |
| Quarter ended Dec 2015 | $5.89B | +$810.00M | +15.94% |
| Quarter ended Sep 2015 | $5.08B | −$303.00M | -5.63% |
| Quarter ended Jun 2015 | $5.38B | +$537.00M | +11.08% |
| Quarter ended Mar 2015 | $4.85B | −$975.00M | -16.75% |
| Quarter ended Dec 2014 | $5.82B | +$354.00M | +6.47% |
| Quarter ended Sep 2014 | $5.47B | −$13.00M | -0.24% |
| Quarter ended Jun 2014 | $5.48B | +$298.00M | +5.75% |
| Quarter ended Mar 2014 | $5.18B | −$734.00M | -12.40% |
| Quarter ended Dec 2013 | $5.92B | +$603.00M | +11.35% |
| Quarter ended Sep 2013 | $5.31B | −$62.00M | -1.15% |
| Quarter ended Jun 2013 | $5.38B | +$153.00M | +2.93% |
| Quarter ended Mar 2013 | $5.22B | −$438.00M | -7.74% |
| Quarter ended Dec 2012 | $5.66B | +$433.00M | +8.28% |
| Quarter ended Sep 2012 | $5.23B | +$263.00M | +5.30% |
| Quarter ended Jul 2012 | $4.96B | −$50.00M | -1.00% |
| Quarter ended Apr 2012 | $5.01B | −$443.00M | -8.12% |
| Quarter ended Dec 2011 | $5.46B | +$218.00M | +4.16% |
| Quarter ended Oct 2011 | $5.24B | +$25.00M | +0.48% |
| Quarter ended Jul 2011 | $5.21B | +$159.00M | +3.14% |
| Quarter ended Apr 2011 | $5.06B | −$124.00M | -2.39% |
| Quarter ended Dec 2010 | $5.18B | +$471.00M | +10.00% |
| Quarter ended Oct 2010 | $4.71B | −$47.00M | -0.99% |
| Quarter ended Jul 2010 | $4.76B | −$23.00M | -0.48% |
| Quarter ended Apr 2010 | $4.78B | −$850.00M | -15.10% |
| Quarter ended Dec 2009 | $5.63B | +$862.00M | +18.08% |
| Quarter ended Sep 2009 | $4.77B | −$30.00M | -0.63% |
| Quarter ended Jun 2009 | $4.80B | +$189.00M | +4.10% |
| Quarter ended Mar 2009 | $4.61B | −$1.06B | -18.66% |
| Quarter ended Dec 2008 | $5.67B | +$470.00M | +9.05% |
| Quarter ended Sep 2008 | $5.20B | −$312.00M | -5.67% |
| Quarter ended Jun 2008 | $5.51B | +$384.00M | +7.50% |
| Quarter ended Mar 2008 | $5.12B | −$598.00M | -10.45% |
| Quarter ended Dec 2007 | $5.72B | +$822.00M | +16.78% |
| Quarter ended Sep 2007 | $4.90B | −$130.00M | -2.59% |
| Quarter ended Jul 2007 | $5.03B | +$227.00M | +4.73% |
| Quarter ended Apr 2007 | $4.80B | +$106.00M | +2.26% |
| Quarter ended Dec 2006 | $4.70B | +$405.00M | +9.44% |
| Quarter ended Oct 2006 | $4.29B | −$60.00M | -1.38% |
| Quarter ended Jul 2006 | $4.35B | +$256.00M | +6.25% |
| Quarter ended Apr 2006 | $4.09B | −$467.00M | -10.24% |
| Quarter ended Dec 2005 | $4.56B | +$401.00M | +9.64% |
| Quarter ended Oct 2005 | $4.16B | −$117.00M | -2.73% |
| Quarter ended Jul 2005 | $4.28B | +$151.00M | +3.66% |
| Quarter ended Apr 2005 | $4.13B | −$528.00M | -11.34% |
| Quarter ended Dec 2004 | $4.66B | +$801.00M | +20.78% |
| Quarter ended Sep 2004 | $3.85B | +$143.00M | +3.85% |
| Quarter ended Jun 2004 | $3.71B | +$71.00M | +1.95% |
| Quarter ended Mar 2004 | $3.64B | −$414.00M | -10.21% |
| Quarter ended Dec 2003 | $4.05B | +$626.00M | +18.26% |
| Quarter ended Sep 2003 | $3.43B | +$32.00M | +0.94% |
| Quarter ended Jun 2003 | $3.40B | +$143.00M | +4.40% |
| Quarter ended Mar 2003 | $3.25B | −$97.00M | -2.90% |
| Quarter ended Dec 2002 | $3.35B | +$344.00M | +11.44% |
| Quarter ended Sep 2002 | $3.01B | N/A | N/A |